Mechanism of salidroside in the treatment of chronic myeloid leukemia based on the network pharmacology and molecular docking-Reference-Cited by-同舟云学术

Mechanism of salidroside in the treatment of chronic myeloid leukemia based on the network pharmacology and molecular docking

Published:2022-11-11 Issue:2 Volume:25 Page:384-395
ISSN:1699-3055
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Chai Yihong,Chen Feng,Li Zijian,Yang Panpan,Zhou Qi,Liu Wenling,Xi Yaming^ORCID

Funder

First Clinical Medical School, Lanzhou University

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12094-022-02990-w.pdf

Reference47 articles.

1. Thielen N, Ossenkoppele GJ, Schuurhuis GJ, Janssen JJ. New insights into the pathogenesis of chronic myeloid leukaemia: towards a path to cure. Neth J Med. 2011;69(10):430–40.

2. Perrotti D, Jamieson C, Goldman J, Skorski T. Chronic myeloid leukemia: mechanisms of blastic transformation. J Clin Invest. 2010;120(7):2254–64. https://doi.org/10.1172/JCI41246.

3. Flis S, Chojnacki T. Chronic myelogenous leukemia, a still unsolved problem: pitfalls and new therapeutic possibilities. Drug Des Devel Ther. 2019;13:825–43. https://doi.org/10.2147/DDDT.S191303.

4. Amir M, Javed S. A review on the therapeutic role of TKIs in case of CML in combination with epigenetic drugs. Front Genet. 2021. https://doi.org/10.3389/fgene.2021.742802.

5. Wolfe HR, Rein LAM. The evolving landscape of frontline therapy in chronic phase chronic myeloid leukemia (CML). Curr Hematol Malig Rep. 2021;16(5):448–54. https://doi.org/10.1007/s11899-021-00655-z.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Key ingredients in Verbena officinalis and determination of their anti-atherosclerotic effect using a computer-aided drug design approach;Frontiers in Plant Science;2023-04-03